Marco Mannes
Overview
Explore the profile of Marco Mannes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Mannes M, Mastellos D, Ekdahl K, Nilsson B, Yancopoulou D, Lambris J, et al.
Semin Immunol
. 2022 Jul;
60:101640.
PMID: 35853795
Patients in the intensive care unit (ICU) often straddle the divide between life and death. Understanding the complex underlying pathomechanisms relevant to such situations may help intensivists select broadly acting...
12.
Stratmann A, Wohlgemuth L, Erber M, Bernhard S, Hug S, Fauler M, et al.
Biomedicines
. 2021 Nov;
9(11).
PMID: 34829733
Neutrophils provide rapid and efficient defense mechanisms against invading pathogens. Upon stimulation with proinflammatory mediators, including complement factors and bacterial peptides, neutrophils respond with changes in their membrane potential, intracellular...
13.
Mannes M, Schmidt C, Nilsson B, Ekdahl K, Huber-Lang M
Semin Immunopathol
. 2021 Jun;
43(6):773-788.
PMID: 34191093
Complement is one of the most ancient defense systems. It gets strongly activated immediately after acute injuries like trauma, burn, or sepsis and helps to initiate regeneration. However, uncontrolled complement...
14.
Dopler A, Stibitzky S, Hevey R, Mannes M, Guariento M, Hochsmann B, et al.
Front Immunol
. 2021 Mar;
12:615748.
PMID: 33732239
To discriminate between self and non-self surfaces and facilitate immune surveillance, the complement system relies on the interplay between surface-directed activators and regulators. The dimeric modulator FHR-1 is hypothesized to...
15.
Mannes M, Dopler A, Zolk O, Lang S, Halbgebauer R, Hochsmann B, et al.
Blood
. 2021 Jan;
137(4):443-455.
PMID: 33507296
Blocking the terminal complement pathway with the C5 inhibitor eculizumab has revolutionized the clinical management of several complement-mediated diseases and has boosted the clinical development of new inhibitors. Data on...
16.
Mannes M, Dopler A, Huber-Lang M, Schmidt C
Front Immunol
. 2020 Nov;
11:596415.
PMID: 33178228
The alternative pathway regulator Factor H-like protein 1 (FHL-1) is composed of the first 7 N-terminal complement control protein domains of Factor H (FH) and protects host surfaces from uncontrolled...
17.
Huber-Lang M, Ignatius A, Kohl J, Mannes M, Braun C
Br J Pharmacol
. 2020 Sep;
178(14):2863-2879.
PMID: 32880897
Physical trauma represents a major global burden. The trauma-induced response, including activation of the innate immune system, strives for regeneration but can also lead to post-traumatic complications. The complement cascade...